Alzheimer's & Dementia, 2024 Osteopontin: A novel marker of pre‐symptomatic sporadic Alzheimer's disease Quesnel M., Labonté A., Picard C. et al. Olink Target 96NeurologyPathophysiologyPatient StratificationCSF | | | | |
CNS Neuroscience & Therapeutics, 2024 Shared genetics and causal association between plasma levels of SARS‐CoV‐2 entry receptor ACE2 and Alzheimer's disease Zhang Y., Xu F., Wang T. et al. Olink Target 96NeurologyInfectious DiseasesPathophysiologyPlasma | | | | |
Journal for ImmunoTherapy of Cancer, 2024 Immune cell topography of head and neck cancer Muijlwijk T., Nijenhuis D., Ganzevles S. et al. Olink Target 96OncologyPathophysiologyTissue Culture Conditioned Medium | | | | |
Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2024 Computational approaches for clinical, genomic and proteomic markers of response to glucagon-like peptide-1 therapy in type-2 diabetes mellitus: An exploratory analysis with machine learning algorithms Villikudathil A., Mc Guigan D., English A. Olink Target 96Metabolic DiseasesPatient StratificationData SciencePlasma | | | | |
Nature Communications, 2024 Determinants of transthyretin levels and their association with adverse clinical outcomes among UK Biobank participants Shetty N., Gaonkar M., Patel N. et al. Olink Explore 3072/384CVDPatient StratificationPlasma | | | | |
ESC Heart Failure, 2024 Mesenchymal stromal cells to treat patients with non‐ischaemic heart failure: Results from SCIENCE II pilot study Qayyum A., Frljak S., Juhl M. et al. Olink Target 96CVDPathophysiologyPlasma | | | | |
ESC Heart Failure, 2024 IL‐17 is associated with disease severity and targetable inflammatory processes in heart failure Baumhove L., van Essen B., Dokter M. et al. Olink Target 96CVDPathophysiologySerum | | | | |
Journal of Proteome Research, 2024 Olink Proteomics-Based Exploration of Immuno-Oncology-Related Biomarkers Leading to Lung Adenocarcinoma Progression Yu S., Yang L., Shu J. et al. Olink Target 96OncologyPathophysiologyPatient StratificationTissue Lysate | | | | |
Archives of Dermatological Research, 2024 Ritlecitinib, a JAK3/TEC family kinase inhibitor, stabilizes active lesions and repigments stable lesions in vitiligo Yamaguchi Y., Peeva E., Duca E. et al. Olink Target 96Immunological & Inflammatory DiseasesDermatological DiseasesPathophysiologySerum | | | | |
Clinical Cancer Research, 2024 Novel Combinations of Immunotherapies or DNA Damage Repair Inhibitors in Platinum-Refractory Extensive-Stage Small Cell Lung Cancer: The Phase II BALTIC Study Reinmuth N., Juan-Vidal O., Kowalski D. et al. Olink Target 96OncologyImmunotherapyPathophysiologyPlasma | | | | |
Journal of Endocrinological Investigation, 2024 Serum proteome signatures associated with liver steatosis in adolescents with obesity Giraudi P., Pascut D., Banfi C. et al. Olink Target 96Metabolic DiseasesHepatologyPatient StratificationSerum | | | | |
Journal of Proteome Research, 2024 Characterization of Inflammatory Mediators and Metabolome in Interstitial Fluid Collected with Dermal Open Flow Microperfusion before and at the End of Dupilumab Treatment in Atopic Dermatitis Monedeiro F., Ehall B., Tiffner K. et al. Olink Target 48Immunological & Inflammatory DiseasesDermatological DiseasesPathophysiologyPlasmaInterstitial Fluid | | | | |
Critical Care Explorations, 2024 Can Biomarkers Correctly Predict Ventilator-associated Pneumonia in Patients Treated With Targeted Temperature Management After Cardiac Arrest? An Exploratory Study of the Multicenter Randomized Antibiotic (ANTHARTIC) Study Deye N., Le Gouge A., François B. et al. Olink Target 96Infectious DiseasesPatient StratificationSerum | | | | |
Journal of Investigative Dermatology, 2024 Dermal white adipose tissue derived IL-33 regulates interleukin 4/13 expression in myeloid cells during inflammation Ertel A., Anderegg U., Franz S. et al. Olink Target 48 MouseImmunological & Inflammatory DiseasesTissue Culture Conditioned Medium | | | | |
Clinical Immunology, 2024 Targeted serum proteome profiling reveals nicotinamide adenine dinucleotide phosphate (NADPH)-related biomarkers to discriminate linear IgA bullous disorder from dermatitis herpetiformis Wang T., Li L., Cao S. et al. Olink Target 96Immunological & Inflammatory DiseasesDermatological DiseasesPathophysiologyPatient StratificationSerum | | | | |
Science, 2024 Combined JAK inhibition and PD-1 immunotherapy for non–small cell lung cancer patients Mathew D., Marmarelis M., Foley C. et al. Olink Target 96OncologyImmunotherapyPathophysiologyPlasma | | | | |
Nature Medicine, 2024 Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial Horwitz S., Nirmal A., Rahman J. et al. Olink Target 96OncologyPathophysiologyPlasma | | | | |
Journal of Proteome Research, 2024 Potential Immune-Inflammatory Proteome Biomarkers for Guiding the Treatment of Patients with Primary Acute Angle-Closure Glaucoma Caused by COVID-19 Gong Q., Fu M., Wang J. et al. Olink Target 96Infectious DiseasesOphthalmologyPathophysiologyAqueous Humor | | | | |
European Heart Journal: Acute Cardiovascular Care, 2024 Targeted proteomic profiling of cardiogenic shock in the cardiac intensive care unit Patel S., Lopes M., Morrow D. et al. Olink Target 96CVDPatient StratificationBlood | | | | |
Frontiers in Immunology, 2024 The predictive value of TNF family for pulmonary tuberculosis: a pooled causal effect analysis of multiple datasets Mo W., Cui Z., Zhao J. et al. Olink Target 96Infectious DiseasesPathophysiologyPlasma | | | | |